- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT04046458
De-escalating Vital Sign Checks
Using Predictive Analytics to Reduce Vital Sign Checks in Stable Hospitalized Patients
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
Patients in the hospital often report poor sleep. A lack of sleep not only affects a patient's recovery from illness and their overall feeling of wellness, but it is a leading factor in the development of delirium in the hospital. One method for improving sleep in the hospital is to reduce the number of patient care related interruptions that a patient experiences. Vital sign checks at night are one example. In hospitalized patients who are clinically stable, vital sign checks that interrupt sleep are often unnecessary. However, identifying which patients can forego these checks is not a simple task. Currently, the hospital's quality improvement team asks physicians to think about this issue every day and order reduced, or "sleep promotion", vital sign checks on patients they believe could safely tolerate it. The investigators goal is to use a predictive analytics tool to reduce the cognitive burden of this task for busy physicians.
The investigators plan to develop a logistic regression model, trained on data from the electronic health record (EHR), to predict, for a given patient on a given night, whether they could safely tolerate the reduction of overnight vital sign checks. The model will use variables, such as the patient's age, the number of days they have been in the hospital, the vital signs from that day, the lab values from that day, and other clinical variables to make its prediction. The outcome is a binary variable, whether the patient will or will not have abnormal vital signs that night. The training data is retrospective therefore it contains the nighttime vitals that were observed, which the investigators will code as a binary variable and use as the outcome variable for the model to train against.
The investigators will incorporate this algorithm into an EHR alert so physicians can observe its output during their work, and use this information, complemented by their own clinical judgment, to decide about ordering reduced vital sign checks for a given patient.
The investigators will study the effect of this EHR alert on several outcomes: in-hospital delirium (measured by nurse assessment), sleep opportunity (a measurement, based on observational EHR data, of patient care related sleep interruptions), and patient satisfaction (measured by nationally-administered post-hospitalization HCAHPS surveys). Balancing measures, to ensure that reduced vital sign checks do not cause patient harm, will be rapid response calls and code blue calls.
Physician teams will be randomized to either see the EHR alert (intervention arm) or not see the EHR alert.
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
California
-
San Francisco, California, Verenigde Staten, 94143
- UCSF
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Kind
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- All physician teams that operate under the UCSF Division of Hospital Medicine
Exclusion Criteria:
- N/A
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Preventie
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: EHR Alert
Physician teams will observe the EHR alert as they perform their clinical duties in the EHR.
|
A pop-up window in the EHR will notify a physician that their patient has been judged by a predictive algorithm to be safe for reduced overnight vital sign checks.
|
|
Placebo-vergelijker: No Alert
Physician teams will perform their clinical duties in the EHR as usual, with no visible alert.
|
No change to EHR function; no alert visible to providers
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
delirium
Tijdsspanne: average will be measured at study completion (6 months from study start date - Sep 11, 2019)
|
Nursing Delirium Screening Scale (Nu-DESC score) - assessed by the nurse, can range from zero to ten, a score > 2 has good accuracy for delirium
|
average will be measured at study completion (6 months from study start date - Sep 11, 2019)
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
sleep opportunity
Tijdsspanne: average will be calculated at study completion (6 months from study start date - Sep 11, 2019)
|
a *novel* measurement based on observational EHR data - for every night in the hospital, the investigators can extract from the EHR all event timestamps that could have interrupted the patient's sleep (measured between 11 pm and 6 am).
These are blood pressure recordings, fingerstick glucose checks, blood draws for labs, and not-as-needed medication administrations.
The maximum time period between such events is considered the patient's sleep opportunity for that night (measured in hours).
A higher sleep-opportunity on a given night is better.
The investigators can calculate an average sleep-opportunity for a hospital encounter and then an average sleep-opportunity for all encounters in a clinical trial arm.
|
average will be calculated at study completion (6 months from study start date - Sep 11, 2019)
|
|
patient satisfaction
Tijdsspanne: average score will be measured at study completion (6 months from study start date - Sep 11, 2019)
|
results from Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) surveys administered to patients after discharge from the hospital (scale is a categorical response: never, sometimes, usually, or always)
|
average score will be measured at study completion (6 months from study start date - Sep 11, 2019)
|
Andere uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
number of code blue events
Tijdsspanne: average number will be calculated at study completion (6 months from study start date - Sep 11, 2019)
|
when a patient has a code blue (respiratory or cardiac arrest) called on them in the hospital, the resuscitation team that responds then writes a note documenting the event; the investigators can count these notes as a proxy for counting code blue events themselves (lower number is better)
|
average number will be calculated at study completion (6 months from study start date - Sep 11, 2019)
|
|
number of rapid response calls
Tijdsspanne: average number will be calculated at study completion (6 months from study start date - Sep 11, 2019)
|
when a patient has a rapid response (significant change in vital signs or alertness) called on them in the hospital, the team that responds writes a note documenting the event and the investigators can count these notes as a proxy for counting rapid response events themselves (lower number is better)
|
average number will be calculated at study completion (6 months from study start date - Sep 11, 2019)
|
Medewerkers en onderzoekers
Onderzoekers
- Studie directeur: Mark Pletcher, MD, Director of the UCSF Informatics and Research Innovation Program
Publicaties en nuttige links
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- nightvitals
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Delirium
-
Alexandria UniversityVoltooidClozapine-vergiftiging | Hypoactief delirium | Tricyclische antidepressiva vergiftiging | Anticholinerge Delirium | Antipsychotische toxiciteit | CZS-depressie | Procyclidine-geïnduceerd deliriumEgypte
-
Efficacy Care R&D LtdHadassah Medical OrganizationOnbekendDelirium | Delirium, oorzaak onbekend | Delirium van gemengde oorsprong | Delirium Verwarde toestand | Door drugs geïnduceerd deliriumIsraël
-
Sengkang General HospitalWervingDelirium en postoperatieve cognitieve disfunctie (POCD) | Delirium, postoperatief | Delirium - PostoperatiefSingapore
-
Johns Hopkins UniversityNational Institute on Aging (NIA)VoltooidDelirium | Delirium bij opkomst | Gehoorverlies | Gehoorverlies, hoge frequentie | Gehoorverlies, perceptief | Delirium, oorzaak onbekend | Gehoorverlies, Bilateraal | Slechthorendheid | Delirium op oudere leeftijd | Delirium van gemengde oorsprong | Delirium bovenop dementie | Delirium Verwarde toestand | Delirium... en andere voorwaardenVerenigde Staten
-
Oslo University HospitalUniversity of Melbourne; Norwegian Academy of MusicVoltooidDelirium op oudere leeftijd | Delirium van gemengde oorsprong | Delirium bovenop dementie | Delirium Verwarde toestandNoorwegen
-
Universitat de LleidaHospital d'IgualadaNog niet aan het wervenDelirium op oudere leeftijd | Delirium behandeling | Delirium Verwarde toestandSpanje
-
Universidad de SantanderOnbekendDelirium van gemengde oorsprong | Hypoactief delirium | Hyperactief deliriumColombia
-
Wonkwang University HospitalVoltooid
-
Beth Israel Deaconess Medical CenterMassachusetts General Hospital; Columbia University; Ohio State UniversityWervingDelirium op oudere leeftijd | Delirium, postoperatiefVerenigde Staten
-
Nanjing First Hospital, Nanjing Medical UniversityActief, niet wervendPostoperatief delirium (POD)China
Klinische onderzoeken op Nighttime Vital Sign EHR Alert
-
Medical University of South CarolinaSouth Carolina Clinical & Translational Research Institute (SCTR)Actief, niet wervendTabaksgebruiksstoornisVerenigde Staten
-
Medical University of South CarolinaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...WervingMetabole disfunctie-geassocieerde steatotische leverziekteVerenigde Staten
-
Sunnybrook Health Sciences CentreCanadian Consortium on Neurodegeneration in AgingWervingDementie | Ziekte van Alzheimer | Slaapapneu | Milde cognitieve stoornisCanada
-
Sunnybrook Health Sciences CentreAlzheimer Society of CanadaWerving
-
University Hospital, Basel, SwitzerlandClinical Trial Unit, University Hospital Basel, SwitzerlandVoltooid
-
Hamilton Health Sciences CorporationMcMaster University; Population Health Research Institute; Cloud DX Inc.Nog niet aan het werven
-
Darma Inc.Virginia Commonwealth UniversityVoltooidBewaking van vitale functiesVerenigde Staten
-
Hamilton Health Sciences CorporationMcMaster University; Population Health Research Institute; Cloud DX Inc.VoltooidVerificatieprotocol voor de Cloud DX Vitaliti Continuous Vital Signs Monitor (VERDICT-2) (VERDICT-2)Bloeddruk | Ademhaling | Temperatuur | Hartslag | Zuurstofverzadiging | HartslagCanada
-
Jaeb Center for Health ResearchActief, niet wervendTaaislijmziekteVerenigde Staten